Levetiracetam chemical structure of levetiracetam

Find information on thousands of medical conditions and prescription drugs.

Keppra

Levetiracetam (brand name: Keppra®) is an anticonvulsant medication used to treat epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam (Nootropil®). Along with other anticonvulsants like gabapentin (Neurontin®), it is also sometimes used to treat neuropathic pain. more...

Home

Diseases

Medicines

Clonazepam

K-Dur

Kadian

Kainic acid

Kanamycin

Kantrex

Kariva

Kayexalate

Keflex

Kefzol

Kemstro

Keppra

Ketalar

Ketek

Kionex

Klotrix

Konazol

Korostatin

Kytril

Side effects

Side effects include: ataxia (sudden loss of balance); hair loss; pins and needles sensation in the extremities; sudden, intense feelings of rage; vivid dreams; and many other common side effects like headache and nausea.

Read more at Wikipedia.org

• [List your site here Free!]



	New Data on the Use of Keppra(R) (levetiracetam) as Adjunctive Treatment in Idiopathic Generalised Epilepsy Patients with Primary Generalised Tonic-Clonic Brussels, 6 December 2005: According to new data, presented at a UCB sponsored Scientific Exhibit at the 59th Annual Meeting of the American Epilepsy Society in Washington, DC, U.S., appr From Market Wire, 12/6/05

	Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment for Myoclonic Seizures UCB Pharma, Inc. today announced that it filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) for the use ... From Market Wire, 10/27/05

	Inclone/Ucb To Develop/Commercialize Cdp-791 ImClone Systems Incorporated (NASDAQ: IMCL) and UCB have entered into a worldwide strategic partnership for the development and commercialization of ... From Worldwide Biotech, 10/1/05

	"Pacemaker for the brain" may help stop seizures Dear Dr. SerVaas, My 20-year-old grandson developed epilepsy, having his first grand mal 3/23/01 when he was 17. Three years previous to that, there ... From Saturday Evening Post, 9/1/05 by Cory SerVaas

	FDA Approves UCB's Keppra(R) for Use in Childhood Epilepsy UCB Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the company's anti-epilepsy drug Keppra® (levetiracetam) ... From Market Wire, 6/24/05

	FDA Grants Priority Review to Keppra(R) for Use in Childhood Epilepsy UCB Pharma, Inc. has been granted a priority review for the supplemental new drug application (sNDA) seeking approval of its leading anti-epilepsy drug ... From Market Wire, 2/17/05

	Discontinuing valproate may reverse PCOS in some women BRECKENRIDGE, COLO. -- Hormonal evidence of polycystic ovary syndrome in patients on valproate is often reversed by a switch to one of the newer antiepileptic ... From OB/GYN News, 3/1/05

	Regulatory Filings Submitted to FDA for a Pediatric Indication and an Intravenous Formulation of Epilepsy Drug Keppra(R) (levetiracetam) UCB Pharma, Inc., today announced that it filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) for a pediatric ... From Market Wire, 12/22/04

Home

Contact

Resources

Exchange Links

ebay